pharma · Ulcerative colitis · central nervous system (CNS) lymphomas · RANI
Rani Therapeutics Holdings
Rani Therapeutics Holdings patent portfolio — 148 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- San Jose, USA
- Founded
- 2012
- Employees
- 99
- Programs
- 7
- Drugs
- 12
- Patents
- 148
Rani Therapeutics Holdings patents
148 pharmaceutical patents indexed for Rani Therapeutics Holdings. 1 expire within 24 months.
Rani Therapeutics Holdings has 148 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6689404
Agent for regulating iodine exchange or for preventing iodine-deficit conditions
expired -
US 6629970
Method of restoring endothelium of cornea
expired -
US 6518247
Method for producing an antitumoral agent and antitumoral agent thus obtained
expired -
US 6261752
Alkaline soluble mixture composed of cellulose derivatives
expired
Frequently asked questions
How many patents does Rani Therapeutics Holdings have?
148 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Rani Therapeutics Holdings patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.